Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo

作者：Marina Antillón, Ching-I Huang, Samuel A. Sutherland, Ronald E. Crump, Paul E. Brown, Paul R. Bessell, Emily Crowley, Rian Snijders, Andrew Hope, Iñaki Tirados, Sophie Dunkley, Paul Verlé, Junior Lebuki, Chansy Shampa, Erick Mwamba Miaka, Fabrizio Tediosi, Kat S. Rock · 发表于：medRxiv · 年份：2024 · DOI：10.1101/2024.03.29.24305066 · 被引用次数：6 · 研究领域：Adolescent and Pediatric Healthcare

Abstract Background Gambiense human African trypanosomiasis (gHAT) is marked for elimination of transmission (EoT) by 2030. We examined the cost-effectiveness (CE) of EoT in the Democratic Republic of Congo, which has the highest global gHAT burden. Methods In 165 health zones (HZs), we modelled the transmission dynamics, health outcomes, and economic costs of six strategies during 2026–40, including the cessation of activities after cases reported reach zero. Uncertainty in CE was assessed within the net monetary framework, which presents the optimal strategies at a range of willingness- to-pay (WTP) values, denominated in costs per disability-adjusted life-year averted. We assessed the optimal strategy for CE and EoT in each health zone separately, but we present results by health zone as well as aggregated by coordination and for the whole country. Results Status quo strategies, CE strategies (WTP=$500), and strategies with a high probability of EoT by 2030 are predicted to yield EoT by 2030 in 118 HZs, 123 HZs, and 134 HZs respectively, at a cost by 2040 of $67.8M [95% PI: $36.7M–113M], $93.3M [95% PI: $51.6M–153M], $185M [95% PI: $111M–309M]. A more lenient timeline of EoT by 2040 could lead to EoT in 152 HZs at a cost of $158M [95% PI: $91.6-265M], leaving 13 HZs shy of the goal. Costs would have to be front-loaded; in 2026, while status quo strategies would cost $8.75M [95% PI: $7.01M–11.2M], elimination strategies would cost $27.0 [95% PI: $21.0M–35.2M]. Investing in ...